CHICAGO, ILLINOIS--(Marketwire - July 24, 2007) - MonoGen, Inc. (“Corporation”) (TSX:MOG) today announced that it submitted its PMA Supplement for the use of the MonoPrep Pap Test with the Digene hc2 HPV DNA Tests before the end of June as expected.
CHICAGO, ILLINOIS--(Marketwire - July 24, 2007) - MonoGen, Inc. (“Corporation”) (TSX:MOG) today announced that it submitted its PMA Supplement for the use of the MonoPrep Pap Test with the Digene hc2 HPV DNA Tests before the end of June as expected.
